We are live on
!
Find out more
Winslow Capital Management Portfolio holdings
AUM
$25.6B
1-Year Est. Return
33.75%
This Fund
S&P 500
This Quarter
Est. Return
-3.93%
1 Year Est. Return
+33.75%
3 Year Est. Return
+154.66%
5 Year Est. Return
+213.06%
10 Year Est. Return
+1,176.94%
AUM
$17.1B
AUM Growth
-$1.62B
(-8.6%)
Cap. Flow
-$749M
Cap. Flow
% of AUM
-4.38%
Top 10 Holdings %
Top 10 Hldgs %
38.73%
Holding
60
New
1
Increased
13
Reduced
39
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$571M |
| 2 |
AstraZeneca
AZN
|
+$211M |
| 3 |
SLB Ltd
SLB
|
+$200M |
| 4 |
Tesla
TSLA
|
+$154M |
| 5 |
Visa
V
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$327M |
| 2 |
Nike
NKE
|
+$282M |
| 3 |
Advanced Micro Devices
AMD
|
+$221M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$146M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$146M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.95% |
| 2 | Healthcare | 18.91% |
| 3 | Consumer Discretionary | 18.35% |
| 4 | Financials | 10.64% |
| 5 | Consumer Staples | 7.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Analog Devices
ADI
$190B
| $319M | 1.87% |
2,290,810
+102,628
| +5% | +$16.2M |
|
|
ABMD
27
DELISTED
Abiomed Inc
ABMD
| $308M | 1.8% |
1,251,859
-25,734
| -2% | -$6.95M |
|
28
lululemon athletica
LULU
$14.6B
| $305M | 1.78% |
1,090,937
-177,509
| -14% | -$55M |
|
29
IQVIA
IQV
$39.3B
| $289M | 1.69% |
1,595,774
-41,155
| -3% | -$9.02M |
|
30
CSX Corp
CSX
$93.1B
| $267M | 1.56% |
10,040,571
+2,529,528
| +34% | +$78.6M |
|
31
Palo Alto Networks
PANW
$297B
| $266M | 1.56% |
3,249,446
-1,068,082
| -25% | -$92.5M |
|
32
Estee Lauder
EL
$32B
| $265M | 1.55% |
1,228,616
-114,267
| -9% | -$29.2M |
|
33
McDonald's
MCD
$195B
| $240M | 1.4% |
1,039,343
-262,355
| -20% | -$67.1M |
|
34
Veeva Systems
VEEV
$37.4B
| $235M | 1.37% |
1,423,786
-161,997
| -10% | -$32.4M |
|
35
NVIDIA
NVDA
$5.42T
| $231M | 1.35% |
19,040,410
-4,453,520
| -19% | -$70.4M |
|
36
MSCI
MSCI
$40.9B
| $223M | 1.31% |
529,814
-61,259
| -10% | -$28M |
|
37
Idexx Laboratories
IDXX
$46.2B
| $217M | 1.27% |
664,697
+142,721
| +27% | +$52.4M |
|
38
ServiceNow
NOW
$129B
| $204M | 1.19% |
2,697,360
-1,426,855
| -35% | -$128M |
|
39
Moody's
MCO
$82.7B
| $199M | 1.16% |
816,824
-28,531
| -3% | -$8.29M |
|
40
Bio-Techne
TECH
$11.3B
| $196M | 1.15% |
2,762,968
-337,428
| -11% | -$29.2M |
|
|
41
AstraZeneca
AZN
$250B
| $190M | 1.11% |
1,730,031
+1,664,956
| +2,559% | +$211M |
|
42
CoStar Group
CSGP
$12.3B
| $136M | 0.8% |
1,956,196
-2,013,025
| -51% | -$140M |
|
43
Adobe
ADBE
$105B
| $127M | 0.75% |
463,137
-79,608
| -15% | -$30.1M |
|
|
44
Nike
NKE
$61.9B
| $123M | 0.72% |
1,480,447
-2,617,416
| -64% | -$282M |
|
45
Atlassian
TEAM
$37.8B
| $122M | 0.71% |
578,879
-572,290
| -50% | -$134M |
|
46
Blackstone
BX
$110B
| $117M | 0.69% |
1,400,622
-525,348
| -27% | -$50.9M |
|
|
47
Advanced Micro Devices
AMD
$789B
| $79.1M | 0.46% |
1,248,824
-2,598,105
| -68% | -$221M |
|
|
PTRA
48
DELISTED
Proterra Inc. Common Stock
PTRA
| $27.4M | 0.16% |
5,510,230
-16,626
| -0.3% | -$93.2K |
|
49
iShares Russell 1000 Growth ETF
IWF
$128B
| $20M | 0.12% |
379,772
-64,264
| -14% | -$3.78M |
|
50
Compass
COMP
$9.66B
| $17.9M | 0.11% |
7,736,612
-8,094
| -0.1% | -$28.7K |
|
Similar funds
UIM
VAI
KK
Winslow Capital Management's Q3 2022 Portfolio in Review
As of Q3 2022, Winslow Capital Management held 60 positions worth $17.1B, down 8.6% from $18.7B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Winslow Capital Management withdrew a net $749M in Q3 2022, closing 4 positions and reducing 39 holdings. Its most notable exit was Salesforce, an estimated $17.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Winslow Capital Management opened a new position in Apple worth $503M.
- Winslow Capital Management's largest Q3 2022 buy was Apple: 3,641,079 shares worth $503M.
- Winslow Capital Management added most to AstraZeneca in Q3 2022, an estimated $211M increase.
- Winslow Capital Management's biggest Q3 2022 reduction was Microsoft, cutting an estimated $327M.
- Winslow Capital Management fully exited Salesforce in Q3 2022, selling an estimated $17.7M.
- Winslow Capital Management's ten largest holdings make up 39% of its $17.1B portfolio in Q3 2022.
- Winslow Capital Management opened 1 new position and closed 4 in Q3 2022.
- Winslow Capital Management's portfolio value fell 8.6% quarter-over-quarter to $17.1B.
Based on Winslow Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.